Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3487972019 | Product containing metformin and repaglinide (medicinal product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
3715705010 | Metformin- and repaglinide-containing product | en | Synonym | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Metformin- and repaglinide-containing product | Is a | Repaglinide-containing product | true | Inferred relationship | Some | ||
Metformin- and repaglinide-containing product | Is a | Metformin-containing product | true | Inferred relationship | Some | ||
Metformin- and repaglinide-containing product | Is a | Combination oral hypoglycaemic | false | Inferred relationship | Some | ||
Metformin- and repaglinide-containing product | Has active ingredient | Repaglinide | true | Inferred relationship | Some | 2 | |
Metformin- and repaglinide-containing product | Has active ingredient | Metformin | true | Inferred relationship | Some | 1 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Metformin and repaglinide only product | Is a | True | Metformin- and repaglinide-containing product | Inferred relationship | Some | |
Metformin hydrochloride 500 mg and repaglinide 1 mg oral tablet | Is a | False | Metformin- and repaglinide-containing product | Inferred relationship | Some | |
Metformin hydrochloride 500 mg and repaglinide 2 mg oral tablet | Is a | False | Metformin- and repaglinide-containing product | Inferred relationship | Some | |
Metformin- and repaglinide-containing product in oral dose form | Is a | True | Metformin- and repaglinide-containing product | Inferred relationship | Some |
This concept is not in any reference sets